Gene · 6329
Papers1,928
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,928
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular hemin is a reverse use-dependent gating modifier of cardiac voltage-gated Na+ channels. | Biol Chem | 2022 | 36038266 | PubTator, text mining | PubMed |
| Molecular mechanism of the spider toxin κ-LhTx-I acting on the bacterial voltage-gated sodium channel NaChBac. | Front Pharmacol | 2022 | 35991876 | PubTator, text mining | PubMed |
| European Neuromuscular Centre consensus statement on anaesthesia in patients with neuromuscular disorders. | Eur J Neurol | 2022 | 35971866 | PubTator, text mining | PubMed |
| Objective Evaluation of Clinical Actionability for Genes Involved in Myopathies: 63 Genes with a Medical Value for Patient Care. | Int J Mol Sci | 2022 | 35955641 | PubTator, text mining | PubMed |
| Ryanodine receptor 1-mediated Ca2+ signaling and mitochondrial reprogramming modulate uterine serous cancer malignant phenotypes. | J Exp Clin Cancer Res | 2022 | 35953818 | PubTator, text mining | PubMed |
| Severe congenital myasthenic syndromes caused by agrin mutations affecting secretion by motoneurons. | Acta Neuropathol | 2022 | 35948834 | PubTator, text mining | PubMed |
| Integrative Analyses Identify Potential Key Genes and Calcium-Signaling Pathway in Familial Atrioventricular Nodal Reentrant Tachycardia Using Whole-Exome Sequencing. | Front Cardiovasc Med | 2022 | 35924220 | PubTator, text mining | PubMed |
| Genetic spectrum and founder effect of non-dystrophic myotonia: a Japanese case series study. | J Neurol | 2022 | 35907044 | PubTator, text mining | PubMed |
| Pharmacological Screening of Venoms from Five Brazilian Micrurus Species on Different Ion Channels. | Int J Mol Sci | 2022 | 35887062 | PubTator, text mining | PubMed |
| Advances in MUC1-Mediated Breast Cancer Immunotherapy. | Biomolecules | 2022 | 35883508 | PubTator, text mining | PubMed |
| Cardiac ion channel expression in the equine model - In-silico prediction utilising RNA sequencing data from mixed tissue samples. | Physiol Rep | 2022 | 35880716 | PubTator, text mining | PubMed |
| Unwinding and spiral sliding of S4 and domain rotation of VSD during the electromechanical coupling in Nav1.7. | Proc Natl Acad Sci U S A | 2022 | 35878056 | PubTator, text mining | PubMed |
| Sequence CLCN1 and SCN4A genes in patients with nondystrophic myotonia in Chinese people. | Medicine (Baltimore) | 2022 | 35866763 | PubTator, text mining | PubMed |
| A dangerous food binge: a case report of hypokalemic periodic paralysis and review of current literature. | Ital J Pediatr | 2022 | 35841048 | PubTator, text mining | PubMed |
| Simulation and Machine Learning Methods for Ion-Channel Structure Determination, Mechanistic Studies and Drug Design. | Front Pharmacol | 2022 | 35837274 | PubTator, text mining | PubMed |
| The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. | Toxicol In Vitro | 2022 | 35811015 | PubTator, text mining | PubMed |
| Hypokalemic Paresis in a 26-Year-Old Man After Recreational Cannabis Use. | Am J Case Rep | 2022 | 35787624 | PubTator, text mining | PubMed |
| Subcellular dynamics and functional activity of the cleaved intracellular domain of the Na+ channel β1 subunit. | J Biol Chem | 2022 | 35752364 | PubTator, text mining | PubMed |
| A Drug Discovery Approach for an Effective Pain Therapy through Selective Inhibition of Nav1.7. | Int J Mol Sci | 2022 | 35743236 | PubTator, text mining | PubMed |
| Genetic Profile of Patients with Limb-Girdle Muscle Weakness in the Chilean Population. | Genes (Basel) | 2022 | 35741838 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6329/papers?page=16